Risk Factors Incompliance Treatment of Lung Tuberculosis Patient In Kendari City
Abstract
The aim of this study was to analysis the risk factors incompliance treatment of TB patient.in Kendari city. The study was a control case design, with 136 respondents consist of 68 cases and 68 controls .The cases samples were all newly TB patients aged 15 years old and above who incompliance treatment .The control samples were all newly TB patients aged 15 years old and above, who compliance treatment. The analysis of the data with tabulation system and statistics by the SPSS with odds ratio. The results of the study indicated that from three variables assumed risky to incompliance to take medicine, there were four variables found to have risk of incompliance , i.e., knowledge OR is 5,492, and activity supervisor to take medicine OR is 4,166. The conclusion : Knowledge, activity supervisor to take medicine, side effect of the drug and feeling better were constitute risk factors to incompliance treatment of TB patient in kendari city
References
Abarca Tomas, B. et al. (2013) ‘Tuberculosis in migrant populations. A systematic review of the qualitative literature.’, PloS one. United States, 8(12), p. e82440. doi: 10.1371/journal.pone.0082440.
Andayani, S. and Astuti, Y. (2017) ‘Prediksi Kejadian Penyakit Tuberkulosis Paru Berdasarkan Usia Di Kabupaten Ponorogo Tahun 2016-2020’, Indonesian Journal for Health Sciences, 1(2), pp. 29–33. doi: 10.24269/ijhs.v1i2.2017.2.
Buton L (2003) Faktor-Faktor Yang Berhubungan Dengan Kegagalan Konversi (Bta Positif) Pada Akhir Pengobatan Fase Intensif Penderita Tuberkulosis Paru Bta Positif Baru Di Kota Kendari Propinsi Sulawesi Tenggara. Universitas Airlangga.
Darmadi et al. (2003) Manifestasi Oral pada Penderita Tuberkulosis. Unika Atma Jaya.
Fang, X.-H. et al. (2019) ‘Prevalence of and Factors Influencing Anti-Tuberculosis Treatment Non-Adherence Among Patients with Pulmonary Tuberculosis: A Cross-Sectional Study in Anhui Province, Eastern China’, Medical science monitor?: international medical journal of experimental and clinical research. International Scientific Literature, Inc., 25, pp. 1928–1935. doi: 10.12659/MSM.913510.
I Dewa Ayu Made Arda Yuni (2016) ‘Hubungan Fase Pengobatan TB dan Pengetahuan Tentang MDR TB dengan Kepatuhan Pengobatan Pasien TB (Studi di Puskesmas Perak Timur)’, Hubungan Fase Pengobatan TB dan Pengetahuan Tentang MDR TB dengan Kepatuhan Pengobatan Pasien TB (Studi di Puskesmas Perak Timur), 4(3), p. 12. doi: 10.20473/jbe.v4i3.
Lonnroth, K. et al. (2010) ‘Tuberculosis control and elimination 2010-50: cure, care, and social development.’, Lancet (London, England). England, 375(9728), pp. 1814–1829. doi: 10.1016/S0140-6736(10)60483-7.
Madeira de Oliveira, S. et al. (2018) ‘Predictors of noncompliance to pulmonary tuberculosis treatment: An insight from South America’, PLOS ONE. Public Library of Science, 13(9), p. e0202593. Available at: https://doi.org/10.1371/journal.pone.0202593.
Nazahar, R. (1997) Faktor-faktor yang berhubungan dengan perilaku kepatuhan berobat penderita TBC Paru di Poli Paru RS. Persahabatan Jakarta tahun 1995. Universitas Indonesia.
Nizar, M. (2010) Pemberantasan dan Penanggulangan Tuberkulosis. Yogyakarta: penerbit Gosyen Publising.
Padang, Muchtar, N. H. and Herman, D. (2018) ‘Artikel Penelitian Gambaran Faktor Risiko Timbulnya Tuberkulosis Paru pada Pasien yang Berkunjung ke Unit DOTS RSUP Dr . M . Djamil’, Gambaran Faktor Risiko Timbulnya Tuberkulosis Paru pada Pasien yang Berkunjung ke Unit DOTS RSUP Dr. M. Djamil Padang Tahun 2015 Nurul, 7(1), pp. 80–87.
Putri, J. A. (2015) ‘Hubungan Pengetahuan dan Tingkat Pendidikan PMO (Pengawas Minum Obat) Terhadap Kepatuhan Minum Obat Antituberkulosis Pasien TB Paru’, Majority, 4(8), pp. 81–84. Available at: http://juke.kedokteran.unila.ac.id/index.php/majority/article/view/1478/1317.
RSJ Prop.Sultra (2017) Profil RSJ Provinsi Sulawesi Tenggara. Kendari.
El Sahly, H. M. et al. (2004) ‘Recurrent tuberculosis in Houston, Texas: a population-based study.’, The international journal of tuberculosis and lung disease?: the official journal of the International Union against Tuberculosis and Lung Disease. France, 8(3), pp. 333–340.
Suharyo (2013) ‘Determinasi Penyakit Tuberkulosis Di Pedesaan’, KESMAS - Jurnal Kesehatan Masyarakat, 9(1), pp. 85–91. doi: 10.15294/kemas.v9i1.2834.
Wirdani (2004) Hubungan keberadaan Pengawas Menelan Obat (PMO) dengan keteraturan minum obat fase intensif penderita TB paru di Puskesmas Kabupaten Pandeglang tahun 2000. Universitas Indonesia.
World Health Organization (WHO) (2015) Globat Tuberculosis Report. 20th Editi. Geneva, Switzerland: WHO Press.
Zumla, A. et al (2013) ‘The WHO 2014 global tuberculosis report—further to go’, The Lancet Global Health’, Elsevier, 3(1), pp. e10–e12.
Andayani, S. and Astuti, Y. (2017) ‘Prediksi Kejadian Penyakit Tuberkulosis Paru Berdasarkan Usia Di Kabupaten Ponorogo Tahun 2016-2020’, Indonesian Journal for Health Sciences, 1(2), pp. 29–33. doi: 10.24269/ijhs.v1i2.2017.2.
Buton L (2003) Faktor-Faktor Yang Berhubungan Dengan Kegagalan Konversi (Bta Positif) Pada Akhir Pengobatan Fase Intensif Penderita Tuberkulosis Paru Bta Positif Baru Di Kota Kendari Propinsi Sulawesi Tenggara. Universitas Airlangga.
Darmadi et al. (2003) Manifestasi Oral pada Penderita Tuberkulosis. Unika Atma Jaya.
Fang, X.-H. et al. (2019) ‘Prevalence of and Factors Influencing Anti-Tuberculosis Treatment Non-Adherence Among Patients with Pulmonary Tuberculosis: A Cross-Sectional Study in Anhui Province, Eastern China’, Medical science monitor?: international medical journal of experimental and clinical research. International Scientific Literature, Inc., 25, pp. 1928–1935. doi: 10.12659/MSM.913510.
I Dewa Ayu Made Arda Yuni (2016) ‘Hubungan Fase Pengobatan TB dan Pengetahuan Tentang MDR TB dengan Kepatuhan Pengobatan Pasien TB (Studi di Puskesmas Perak Timur)’, Hubungan Fase Pengobatan TB dan Pengetahuan Tentang MDR TB dengan Kepatuhan Pengobatan Pasien TB (Studi di Puskesmas Perak Timur), 4(3), p. 12. doi: 10.20473/jbe.v4i3.
Lonnroth, K. et al. (2010) ‘Tuberculosis control and elimination 2010-50: cure, care, and social development.’, Lancet (London, England). England, 375(9728), pp. 1814–1829. doi: 10.1016/S0140-6736(10)60483-7.
Madeira de Oliveira, S. et al. (2018) ‘Predictors of noncompliance to pulmonary tuberculosis treatment: An insight from South America’, PLOS ONE. Public Library of Science, 13(9), p. e0202593. Available at: https://doi.org/10.1371/journal.pone.0202593.
Nazahar, R. (1997) Faktor-faktor yang berhubungan dengan perilaku kepatuhan berobat penderita TBC Paru di Poli Paru RS. Persahabatan Jakarta tahun 1995. Universitas Indonesia.
Nizar, M. (2010) Pemberantasan dan Penanggulangan Tuberkulosis. Yogyakarta: penerbit Gosyen Publising.
Padang, Muchtar, N. H. and Herman, D. (2018) ‘Artikel Penelitian Gambaran Faktor Risiko Timbulnya Tuberkulosis Paru pada Pasien yang Berkunjung ke Unit DOTS RSUP Dr . M . Djamil’, Gambaran Faktor Risiko Timbulnya Tuberkulosis Paru pada Pasien yang Berkunjung ke Unit DOTS RSUP Dr. M. Djamil Padang Tahun 2015 Nurul, 7(1), pp. 80–87.
Putri, J. A. (2015) ‘Hubungan Pengetahuan dan Tingkat Pendidikan PMO (Pengawas Minum Obat) Terhadap Kepatuhan Minum Obat Antituberkulosis Pasien TB Paru’, Majority, 4(8), pp. 81–84. Available at: http://juke.kedokteran.unila.ac.id/index.php/majority/article/view/1478/1317.
RSJ Prop.Sultra (2017) Profil RSJ Provinsi Sulawesi Tenggara. Kendari.
El Sahly, H. M. et al. (2004) ‘Recurrent tuberculosis in Houston, Texas: a population-based study.’, The international journal of tuberculosis and lung disease?: the official journal of the International Union against Tuberculosis and Lung Disease. France, 8(3), pp. 333–340.
Suharyo (2013) ‘Determinasi Penyakit Tuberkulosis Di Pedesaan’, KESMAS - Jurnal Kesehatan Masyarakat, 9(1), pp. 85–91. doi: 10.15294/kemas.v9i1.2834.
Wirdani (2004) Hubungan keberadaan Pengawas Menelan Obat (PMO) dengan keteraturan minum obat fase intensif penderita TB paru di Puskesmas Kabupaten Pandeglang tahun 2000. Universitas Indonesia.
World Health Organization (WHO) (2015) Globat Tuberculosis Report. 20th Editi. Geneva, Switzerland: WHO Press.
Zumla, A. et al (2013) ‘The WHO 2014 global tuberculosis report—further to go’, The Lancet Global Health’, Elsevier, 3(1), pp. e10–e12.
Published
2020-02-13
How to Cite
ASRIATI, Asriati; ALIFARIKI, La Ode.
Risk Factors Incompliance Treatment of Lung Tuberculosis Patient In Kendari City.
Jurnal Keperawatan Terapan, [S.l.], v. 5, n. 2, p. 103-110, feb. 2020.
ISSN 2442-6873.
Available at: <https://ojs.poltekkes-malang.ac.id/index.php/JKT/article/view/1399>. Date accessed: 26 apr. 2024.
doi: https://doi.org/10.31290/jkt.v5i2.1399.
Section
Original Articles
.jpg)
.png)
